Updated daily
Drug recalls
Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.
Class IITerminatedAug 13, 2014Vitamin B12 Methylcobalamin Injection USP 1000 mcg/mlMarketed without an Approved NDA/ANDA; IM and SQ injectable products are being recalled because the manufacturing firm is not registered with the FDA as a drug...Medical Supply Liquidators Llc · D-1520-1014Class IITerminatedAug 13, 2014Vitamin B12 Methylcobalamin with MIC Injection USP 1000 mcg/mlMarketed without an Approved NDA/ANDA; IM and SQ injectable products are being recalled because the manufacturing firm is not registered with the FDA as a drug...Medical Supply Liquidators Llc · D-1519-2014Class IITerminatedAug 13, 2014Alcohol-Free Hand SanitizerMicrobial Contamination of Non-Sterile ProductHLI dba Humphreyline Inc · D-1518-2014Class IITerminatedAug 13, 2014Tetrahydrozoline HCLCGMP Deviations; Stored/dispensed in a non-GMP compliant warehouse at S.I.M.S., Italy.SST Corporation · D-1517-2014Class IIITerminatedAug 13, 2014CataflamFailed Tablet/Capsule Specifications: Ink identification had rubbed off tablets in transit making them illegible to pharmacists and consumers.Novartis Pharmaceuticals Corp. · D-1516-2014Class IITerminatedAug 13, 2014Alprazolam TabletsPresence of Foreign Substance; tablets may contain stainless steel metal particulatesMckesson Packaging Services · D-1515-2014Class IITerminatedAug 13, 2014Risperdal CONSTANon-Sterility: Janssen is recalling one lot of Risperdal CONSTA (risperiDONE) due to a sterility failure in a stability sampleJanssen Pharmaceuticals, Inc. · D-1514-2014Class IIITerminatedAug 13, 2014buPROPion HCl Extended-Release TabletsFailed Impurities/Degradation Products: Out of specification levels of the impurity m-chlorobenzoic acid were observed.Wockhardt Usa Inc. · D-1513-2014Class ITerminatedAug 13, 2014SolirisPresence of Particulate Matter: Product failed the appearance for the presence of visible particles under labeled storage condition.Alexion Pharmaceuticals, Inc. · D-1512-2014Class IITerminatedAug 13, 2014Cephalexin CapsulesCGMP Deviations: These products are being recalled because they were manufactured with active pharmaceutical ingredients (APIs) that were not manufactured with good...Caraco Pharmaceutical Laboratories, Ltd. · D-1511-2014Class IITerminatedAug 13, 2014Cephalexin CapsulesCGMP Deviations: These products are being recalled because they were manufactured with active pharmaceutical ingredients (APIs) that were not manufactured with good...Caraco Pharmaceutical Laboratories, Ltd. · D-1510-2014Class IITerminatedAug 6, 2014Alprazolam TabletsPresence of Foreign Substance; tablets may contain stainless steel metal particulatesSandoz Incorporated · D-1509-2014Class IITerminatedAug 6, 2014Benicar HCT TabletsTemperature Abuse; various products were not stored at Controlled Room Temperature as per USP guidelines during shipping.Daiichi Sankyo Pharma Development · D-1508-2014Class IITerminatedAug 6, 2014Benicar HCT TabletsTemperature Abuse; various products were not stored at Controlled Room Temperature as per USP guidelines during shipping.Daiichi Sankyo Pharma Development · D-1507-2014Class IITerminatedAug 6, 2014Benicar TabletsTemperature Abuse; various products were not stored at Controlled Room Temperature as per USP guidelines during shipping.Daiichi Sankyo Pharma Development · D-1506-2014Class IITerminatedAug 6, 2014Welchol TabletsTemperature Abuse; various products were not stored at Controlled Room Temperature as per USP guidelines during shippingDaiichi Sankyo Pharma Development · D-1505-2014Class IITerminatedAug 6, 2014Tribenzor TabletsTemperature Abuse; various products were not stored at Controlled Room Temperature as per USP guidelines during shippingDaiichi Sankyo Pharma Development · D-1504-2014Class IITerminatedAug 6, 2014Benicar HCT TabletsTemperature Abuse; various products were not stored at Controlled Room Temperature as per USP guidelines during shippingDaiichi Sankyo Pharma Development · D-1503-2014Class IITerminatedAug 6, 2014Benicar TabletsTemperature Abuse; various products were not stored at Controlled Room Temperature as per USP guidelines during shippingDaiichi Sankyo Pharma Development · D-1502-2014Class IITerminatedAug 6, 2014Azor TabletsTemperature Abuse; various products were not stored at Controlled Room Temperature as per USP guidelines during shippingDaiichi Sankyo Pharma Development · D-1501-2014Class IITerminatedAug 6, 2014Losartan Potassium and Hydrochlorothiazide TabletsPresence of Foreign Substance: Tablets may contain dark blemishes identified as stainless steel.Jubilant Cadista Pharmaceuticals Inc. · D-1500-2014Class IITerminatedAug 6, 2014triple therapyFailed Impurities/Degradation Specifications: This recall is due to out of specification for impurities test results obtained during stability testing for Lansoprazole.Teva Pharmaceuticals USA · D-1499-2014Class IITerminatedAug 6, 2014Fagron, Pentravan Plus Base 2.5 KgMicrobial Contamination of Non-Sterile Products: Fagron is recalling six lots due to the presence of mold.Fagron, Inc · D-1498-2014Class IITerminatedAug 6, 2014Fagron, Pentravan Base 2.5 KgMicrobial Contamination of Non-Sterile Products: Fagron is recalling six lots due to the presence of mold.Fagron, Inc · D-1497-2014Class IITerminatedAug 6, 2014Fagron, Phytobase CreamMicrobial Contamination of Non-Sterile Products: Fagron is recalling six lots due to the presence of mold.Fagron, Inc · D-1496-2014Class IITerminatedAug 6, 2014Therametics Complexion Repair Topical Rehydrating Emulsion in 50 ml and 30 ml containers in the Complexion...Marketed without an Approved NDA/ANDA: FDA has determined that the products are unapproved new drugs and misbranded.Dermamedics, L.L.C. · D-1495-2014Class IITerminatedAug 6, 2014Dermamedics Complexion Repair Topical Rehydrating Emulsion in 50 ml and 30 ml containers in the Dermamedics...Marketed without an Approved NDA/ANDA: FDA has determined that the products are unapproved new drugs and misbranded.Dermamedics, L.L.C. · D-1494-2014Class IITerminatedAug 6, 2014Dermamedics Calm and Correct Cream 2 oz. containers in the Dermamedics Post Medical Procedure Kit with a SKU...Marketed without an Approved NDA/ANDA: FDA has determined that the products are unapproved new drugs and misbranded.Dermamedics, L.L.C. · D-1493-2014Class IITerminatedAug 6, 2014Dermamedics Post Procedure Cream 1 oz. containers in the Dermamedics Post-Laser Treatment System with a SKU...Marketed without an Approved NDA/ANDA: FDA has determined that the products are unapproved new drugs and misbranded.Dermamedics, L.L.C. · D-1492-2014Class IITerminatedAug 6, 2014Dermamedics Calm and Correct SerumMarketed without an Approved NDA/ANDA: FDA has determined that the products are unapproved new drugs and misbranded.Dermamedics, L.L.C. · D-1491-2014Class IITerminatedAug 6, 2014Dermamedics Complexion Repair Topical Rehydrating Emulsion which wasMarketed without an Approved NDA/ANDA: FDA has determined that the products are unapproved new drugs and misbranded.Dermamedics, L.L.C. · D-1490-2014Class IITerminatedAug 6, 2014Dermamedics Baby's Relief Calm and Repair Cream in 2 oz. containers with a SKU number of DM1016 and 0.25...Marketed without an Approved NDA/ANDA: FDA has determined that the products are unapproved new drugs and misbranded.Dermamedics, L.L.C. · D-1489-2014Class IITerminatedAug 6, 2014Dermamedics Calm & Correct Cream in 2 oz. containers with SKU number DM1020Marketed without an Approved NDA/ANDA: FDA has determined that the products are unapproved new drugs and misbranded.Dermamedics, L.L.C. · D-1488-2014Class IITerminatedAug 6, 2014Dermamedics Post Procedure CreamMarketed without an Approved NDA/ANDA: FDA has determined that the products are unapproved new drugs and misbranded.Dermamedics, L.L.C. · D-1487-2014Class IIITerminatedAug 6, 2014OXYCODONE HYDROCHLORIDE C II Oral Solution USPFailed Stability Specifications: Out of specification result for preservative sodium benzoate.Boehringer Ingelheim Roxane Inc · D-1486-2014Class IIITerminatedAug 6, 2014Cardura XLFailed Impurities/Degradation Specifications: Product from this lot may not meet specifications for a product degradant.Pfizer Inc. · D-1485-2014Class IIITerminatedAug 6, 2014Aspirin DR Enteric Coated TabletsFailed Dissolution Specification; at the 12 month time interval.Mckesson Packaging Services · D-1483-2014Class IIOngoingJul 30, 2014Ceftriaxone 1 gm/50 mL D5WLack of Assurance of Sterility; All lots of sterile products compounded by the pharmacy within expiry are subject to this recall. This recall is initiated due to...Franck's Lab Inc dba Trinity Care Solutions · D-1482-2014Class IIOngoingJul 30, 2014Cefepime 2 gm/100 mL 0.9%NSLack of Assurance of Sterility; All lots of sterile products compounded by the pharmacy within expiry are subject to this recall. This recall is initiated due to...Franck's Lab Inc dba Trinity Care Solutions · D-1481-2014Class IIOngoingJul 30, 2014Ceftriaxone 2 gm/100 mL D5WLack of Assurance of Sterility; All lots of sterile products compounded by the pharmacy within expiry are subject to this recall. This recall is initiated due to...Franck's Lab Inc dba Trinity Care Solutions · D-1480-2014